S
SAB Biotherapeutics, Inc. (SABS)
NCM – Real Time Price. Currency in USD
3.77
+0.01 (0.27%)
Market open: Aug 12, 2026, 10:06 AM EDT
3.77
+0.01 (0.27%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
3.77
+0.01 (0.27%)
Market open: Aug 12, 2026, 10:06 AM EDT
3.77
+0.01 (0.27%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
This stock has a consensus price target of $10.86 based on the ratings of 15 analysts. The high is $16.00 and the low is $6.00.
| Target | Lowest Price Target | Consensus Price Target | Highest Price Target |
|---|---|---|---|
| Price | $ 6 | $ 10.86 | $ 16 |
| Change | 58.94% | 187.68% | 323.84% |
| Date | Upside/Downside | Analyst Firm | Price Target | Rating Change | Rating |
|---|---|---|---|---|---|
| 2026-06-24 | 244.83% | Barclays | $13 | Initiates Coverage On | Overweight |
| 2026-06-17 | 324.4% | Chardan Capital | $14 → $16 | Maintains | Buy |
| 2026-06-15 | 218.3% | Leerink Partners | $7 → $12 | Maintains | Outperform |
| 2026-06-15 | 165.25% | HC Wainwright & Co. | $10 → $10 | Reiterates | Buy |
| 2026-05-22 | 191.78% | Citigroup | $11 | Initiates Coverage On | Buy |